Related Experiment Video
Updated: Oct 8, 2025
08:43
Calcification of Vascular Smooth Muscle Cells and Imaging of Aortic Calcification and Inflammation
Published on: May 31, 2016
19.7K
A molecular target of vascular calcification in chronic kidney disease
The Journal of Clinical Investigation
|January 4, 2022
Summary
SIRT6 protein prevents vascular calcification in chronic kidney disease (CKD) by inhibiting the osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs). This research identifies SIRT6 as a potential therapeutic target for treating vascular calcification in CKD patients.
Area of Science:
- Nephrology
- Cardiovascular Biology
- Molecular Medicine
Background:
- Vascular calcification (VC) is a significant complication in chronic kidney disease (CKD), leading to increased cardiovascular morbidity and mortality, especially in end-stage kidney disease (ESKD) patients on dialysis.
- The precise molecular mechanisms underlying VC in CKD remain incompletely understood, necessitating further investigation into potential therapeutic targets.
Purpose of the Study:
- To elucidate the molecular mechanism by which SIRT6 exerts a protective role against vascular calcification (VC) in the context of chronic kidney disease (CKD).
- To investigate the potential of targeting SIRT6 as a therapeutic strategy for managing VC in CKD patients.
Main Methods:
- Employed in vitro and animal models specifically designed to mimic conditions of chronic kidney disease (CKD).
- Investigated the interaction between SIRT6 and the transcription factor Runx2 (runt-related transcription factor 2).
- Utilized techniques to assess protein deacetylation, nuclear export, and proteasomal degradation pathways.
Main Results:
- Demonstrated that SIRT6 effectively prevents vascular calcification (VC) by suppressing the osteogenic transdifferentiation of vascular smooth muscle cells (VSMCs).
- Mechanistically, SIRT6 was shown to bind and deacetylate Runx2, a critical transcription factor for osteogenic differentiation.
- This SIRT6-mediated deacetylation promotes the nuclear export and subsequent proteasomal degradation of Runx2, thereby inhibiting VC.
Conclusions:
- The study identifies a novel molecular pathway in the pathogenesis of vascular calcification (VC) relevant to chronic kidney disease (CKD).
- SIRT6 plays a crucial protective role in preventing VC by regulating VSMC osteogenic transdifferentiation via the Runx2 pathway.
- These findings strongly support the investigation of SIRT6 as a potential therapeutic target for mitigating vascular calcification in CKD.
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
139
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
139
01:25Chronic Kidney Disease I: Introduction
105
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
105
01:28Chronic Kidney Disease III: Interprofessional Care
97
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
97
01:29Acute Kidney Injury II: Pathophysiology
147
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
147
01:18Chronic Kidney Disease IV: Nursing Management
77
Nursing management is essential for preventing complications, maintaining stability, and improving patients' quality of life in chronic kidney disease (CKD). By using a structured approach, nurses help slow CKD progression and support effective patient care.1. Comprehensive patient assessmentEffective management begins with nurses reviewing the patient’s medical history, and identifying key risk factors like diabetes, hypertension, and nephrotoxic drug use. Nurses assess signs of...
77
01:21Skeleton and Calcium Homeostasis
5.0K
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
5.0K